RxSight, Inc. , a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.
Rxsight stock last closed at $27.05, down 0.51% from the previous day, and has increased 141.73% in one year. It has overperformed other stocks in the Medical Devices industry by 1.57 percentage points. Rxsight stock is currently +176.58% from its 52-week low of $9.78, and -19.9% from its 52-week high of $33.77.
As of Sep 25, 2023, there are 35.64M shares of RXST outstanding. The market value of RXST is $964.16M. In the past 24 hours, 231,131 RXST shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy RXST shares.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro now.Open eToro Account
Now that you've picked the best brokerage, the next step is to fill out some personal details so you can buy RXST today.
Now that you've finished signing up on a good stock buying app, you need to deposit funds:
Watch the walkthrough below to see the process of transferring money into your new brokerage account.
After you have figured out the best place to buy Rxsight stock, it's critical to evaluate their stock prior to buying, so you can wrap your head around the risk and upside.
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can view all of the due diligence checks on RXST's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RXST's fair value.
Using relative valuations measures:
You can access more valuation analysis on RXST's stock here.
Out of 4 Wall Street analysts who track RXST, the consensus analyst rating on RXST is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Steven Lichtman, a bottom 14% analyst from Oppenheimer maintains RXST with a buy rating and raises their RXST price target from $29.00 to $34.00, on Aug 8, 2023.
David Saxon, a bottom 11% analyst from Needham reiterates RXST with a buy rating and maintains their RXST price target from $34.00 to $34.00, on Aug 8, 2023.
Ryan Zimmerman, a top 5% analyst from BTIG maintains RXST with a strong buy rating and raises their RXST price target from $25.00 to $29.00, on Jun 5, 2023.
Maintaining his Strong Buy rating, Zimmerman raised his price target on Rxsight Inc. by 16% following a post-Q1 assessment of all the results from the names in his Medical Technology portfolio.
The group is off to a great start to the year, with 84% of companies in his group beating revenue expectations and 64% exceeding earnings estimates, the analyst summarized.
Larry Biegelsen, a top 14% analyst from Wells Fargo maintains RXST with a hold rating and raises their RXST price target from $17.00 to $27.00, on Jun 5, 2023.
You can dive deeper into what analysts are forecasting on the Rxsight stock forecast page.
Last year, RXST revenue was $67.00M. In the last two year, RXST's revenue has grown by 95.87% per year. This was faster than the Medical Devices industry average of 13.03%.
Dig into RXST's earnings and revenue performance here.
Over the last year, executives and large shareholders at RXST have bought more shares than they have sold.
Bakker Juliet Tammenoms, Director of RXST, was the latest RXST insider to sell. They sold $88,523.60 worth of RXST shares on Sep 11, 2023.
Research more about who owns RXST stock here.
No, Rxsight doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two main options:
Hit the Open Trade button and eToro will place your order.
If you require more assistance investing in stocks on eToro, click the how to video below:
Now that you own some RXST shares, you'll want to stay up-to-date on your new stock purchase.
Start a watchlist to track the latest developments regarding your RXST stock.
To summarize, here are the 6 steps you need to take to buy Rxsight stock right now:
If you are looking for a brokerage account, eToro is our recommended venue.Get Started with eToro Today
If you want to keep track of your new investment in Rxsight, hit the button below to create your watchlist.
How much does it cost to buy one Rxsight share?
Is now a good time to buy Rxsight stock?
What is the best way to buy Rxsight stock?